Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Endocrine Reviews|February 10, 2025
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin PathwayMila S Welling, Elisabeth F C van Rossum, Erica L T van den Akker
Obesity Facts|July 2, 2023
The Narrative of a Patient with Leptin Receptor Deficiency: Personalized Medicine for a Rare Genetic Obesity DisorderMila S Welling, Lotte Kleinendorst, Mieke M van Haelst, et al.
Iscience|March 6, 2023
Successful naltrexone-bupropion treatment after several treatment failures in a patient with severe monogenic obesityMila S Welling, Mostafa Mohseni, Eline S van der Valk, et al.
Clinical Obesity|September 13, 2020
COVID-19 related anxiety in children and adolescents with severe obesity: A mixed-methods studyOzair Abawi, Mila S Welling, Emma van den Eynde, et al.
Eclinicalmedicine|July 25, 2024
Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world studyMila S Welling, Cornelis J de Groot, Mostafa Mohseni, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2024
MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple LevelsAlejandra V Rodríguez Rondón, Mila S Welling, Erica L T van den Akker, et al.
Obesity (Silver Spring, Md.)|May 29, 2024
Clinical phenotypes of adults with monogenic and syndromic genetic obesityMila S Welling, Mostafa Mohseni, Renate E H Meeusen, et al.
Pageof 2